Rapid Cas13a-based pen A genotyping for cefixime susceptibility in Neisseria gonorrhoeae

By afschroeder • May 20, 2026

Nguyen THY, Garg S, Adams G, Mantena S, Gopal N, Suk H-J, D Klausner J, Sabeti PC, Lemieux JE, Allan-Blitz L-T. Rapid Cas13a-based penA genotyping for cefixime susceptibility in Neisseria gonorrhoeae. mSphere. 2026 May 19:e0018226. doi: 10.1128/msphere.00182-26. Epub ahead of print. PMID: 42153664.

Tags: antimicrobial resistance, Cas13, cefixime, CRISPR, Infectious Diseases, Neisseria gonorrhoeae, point-of-care, Publications, resistance-guided therapy

Integrating long-acting injectable cabotegravir for HIV prevention into the Brazilian public health system ImPrEP CAB Brasil: a hybrid type-2 implementation-effectiveness cohort study

Grinsztejn B, Torres TS, Hoagland B, Coutinho C, Silva MST, Leite IC, Cunha M, Derrico M, Jalil EM, Cardoso SW, Trefiglio R, Farias A, Mourão[...]

Diagnostics for Hemorrhagic Fever Viruses: Lassa Fever as an Example

Dhar B, Espinoza N, Farzani T, Baudi I, Nosamiefan D, Garcia CY, Allan-Blitz LT, Samani P, Happi C, Sabeti P. Diagnostics for Hemorrhagic Fever Viruses:[...]

Transferrin Enhances Antifungal Therapy and Improves Survival in Experimental Mucormycosis

Gu Y, Gebremariam T, Ibrahim BA, Harb K, Chan A, Ibrahim AS. Transferrin Enhances Antifungal Therapy and Improves Survival in Experimental Mucormycosis. J Fungi (Basel).[...]